Login to Your Account

Market Report Q113

In Q1 Public Biopharmas Shift Fundraising into Overdrive

By Peter Winter

Monday, April 8, 2013

Biotech companies generated $5 billion in the first quarter of 2013, just 3 percent less than the $5.15 billion raised in the first quarter last year. The heavy lifting for the period was carried out by public companies, which were responsible for 65 percent of the total.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription